Who owns FRACTYL HEALTH, INC. (GUTS)? Elite investor 13F holders
2 tracked elite investors reported holding FRACTYL HEALTH, INC as of 2026-06-30, including Maverick Capital, Renaissance Technologies LLC. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.
2 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Health Care Equipment & Services
Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. It develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans. The company also develops Rejuva, a…
Reported holders and securities, including exits (up to 20)
| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|---|---|---|---|---|---|---|---|---|---|
| Maverick Capital | FRACTYL HEALTH INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 3157586.00 USD | 3974806.000000 | Shares | hold | Original filing |
| Renaissance Technologies LLC | FRACTYL HEALTH INC | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 97076.00 USD | 122200.000000 | Shares | add | Original filing |
Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.
This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.